MACKENZIE KELLY: Open Payments
NPI 1699407957 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,835 in 131 payments from 21 companies in 2025. Trend: 2023 $2,311 · 2024 $1,931 · 2025 $2,835
Food & beverage: $2,835
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $395 |
| Verona Pharma, Inc. | 20 | $369 |
| GlaxoSmithKline, LLC. | 25 | $341 |
| AstraZeneca Pharmaceuticals LP | 9 | $272 |
| Actelion Pharmaceuticals US, Inc. | 7 | $186 |
| Axsome Therapeutics, Inc. | 8 | $185 |
| Merck Sharp & Dohme LLC | 6 | $173 |
| Amgen Inc. | 7 | $136 |
| United Therapeutics Corporation | 6 | $116 |
| Viatris Specialty LLC | 4 | $109 |
Products named: DUPIXENT, Ohtuvayre, TRELEGY ELLIPTA, Sunosi, TEZSPIRE, WINREVAIR, AIRSUPRA, Tyvaso.
Industry payments across KY — which companies pay providers there.
